Cemented Marathon/Corail Versus Pinnacle/Corail
Launched by HAUKELAND UNIVERSITY HOSPITAL · Sep 24, 2012
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age under 70 years with primary or secondary arthritis of the hip, aseptic necrosis of the femoral head, acute hip fracture or sequelae after hip fracture.
- Exclusion Criteria:
- • Active malignant disease, rheumatoid arthritis or other generalised auto-immune arthritic disease,
- • BMI \> 35,
- • insulin dependent diabetes mellitus, 0 chronic or recurrent infection,
- • liver disease,
- • Paget's disease,
- • dementia or lack of compliance for other reasons,
- • uncompensated cardiac or pulmonary disease(ASA class 3 or 4). Prosthesis in the contralateral hip does not exclude the patient, but only one hip in each patient can be included in the study.
Trial Officials
Leif I Havelin, MD, PhD
Study Director
Department of Orthopeadic Surgery, Haukeland University Hospital, Bergen, Norway
Benedikt A Jonsson, MD
Principal Investigator
Department of Orthopeadic Surgery, Haukeland University Hospital, Bergen, Norway
Geir Hallan, MD, PhD
Principal Investigator
Department of Orthopeadic Surgery, Haukeland University Hospital, Bergen, Norway
Ove Furnes, MD, PhD
Study Chair
Department of Orthopeadic Surgery, Haukeland University Hospital, Bergen, Norway
Clara G Gjesdal, MD, PhD
Study Chair
Department of Rheumatology, Haukeland University Hospital, Bergen, Norway
Kristin Haugan, MA
Study Chair
Department of Orthopeadic Surgery, Trondheim University Hospital, Trondheim, Norway
Arne K Skredderstuen, MD
Study Chair
Department of Orthopeadic Surgery, Haukeland University Hospital, Bergen, Norway
Terje Stokke
Study Chair
Department of Radiology, Haukeland University Hospital, Bergen, Norway
About Haukeland University Hospital
Haukeland University Hospital, located in Bergen, Norway, is a leading academic medical center renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge clinical studies that aim to advance healthcare outcomes. With a multidisciplinary team of healthcare professionals and researchers, Haukeland University Hospital fosters collaboration and knowledge exchange, ensuring that trials are conducted with the highest standards of ethics, safety, and scientific rigor. Its strategic focus on translational research enhances the bridge between laboratory discoveries and real-world applications, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials